These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7061487)

  • 1. Preparation, characterization, and turnover properties of heparin-antithrombin III complexes stabilized by covalent bonds.
    Ceustermans R; Hoylaerts M; De Mol M; Collen D
    J Biol Chem; 1982 Apr; 257(7):3401-8. PubMed ID: 7061487
    [No Abstract]   [Full Text] [Related]  

  • 2. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the biological activity of antithrombin III in patients with hepatic cirrhosis.
    Matsuo T; Matsuo C; Matsuo O
    Clin Chim Acta; 1984 Jul; 140(2):125-32. PubMed ID: 6467606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies of the turnover of dog antithrombin III. Study of 131I-labelled antithrombin protease complexes.
    Leonard B; Bies R; Carlson T; Reeve EB
    Thromb Res; 1983 Apr; 30(2):165-77. PubMed ID: 6868021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the heterogeneity of antithrombin III concentrates.
    Barrowcliffe TW; Eggleton CA; Mahmoud M
    Br J Haematol; 1983 Sep; 55(1):37-46. PubMed ID: 6882687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.
    Ofosu FA; Modi G; Cerskus AL; Hirsh J; Blajchman MA
    Thromb Res; 1982 Nov; 28(4):487-97. PubMed ID: 7164033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The purification and mechanism of action of human antithrombin-heparin cofactor.
    Rosenberg RD; Damus PS
    J Biol Chem; 1973 Sep; 248(18):6490-505. PubMed ID: 4738234
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.
    Sørensen PJ; Sas G; Petó I; Blaskó G; Kremmer T; Samu A
    Thromb Res; 1982 May; 26(3):211-9. PubMed ID: 7112514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin BM from human plasma: an antithrombin binding moderately to heparin.
    Wunderwald P; Schrenk WJ; Port H
    Thromb Res; 1982 Feb; 25(3):177-91. PubMed ID: 6175043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin.
    Preissner KT; Müller-Berghaus G
    J Biol Chem; 1987 Sep; 262(25):12247-53. PubMed ID: 2442161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E
    Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
    Thomas DP; Merton RE; Barrowcliffe TW; Thunberg L; Lindahl U
    Thromb Haemost; 1982 Jun; 47(3):244-8. PubMed ID: 7112499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of antithrombin III concentrates--a single-blind study.
    Hellstern P; Moberg U; Ekblad M; Anders CU; Faller B; Müller S
    Haemostasis; 1995; 25(4):193-201. PubMed ID: 7557658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous variant of antithrombin III: AT III Fontainebleau.
    Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
    Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approach for preparation of heparins specific to factor Xa using affinity chromatography coupled with synthetic antithrombin III-related peptides.
    Onoue S; Harada S; Nemoto Y; Yajima T; Kashimoto K
    Peptides; 2003 Jun; 24(6):821-6. PubMed ID: 12948833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.